Logo image of GCO

GENESCO INC (GCO) Stock Fundamental Analysis

NYSE:GCO - US3715321028 - Common Stock

33.04 USD
+1.36 (+4.29%)
Last: 9/10/2025, 2:43:03 PM
Fundamental Rating

4

Taking everything into account, GCO scores 4 out of 10 in our fundamental rating. GCO was compared to 123 industry peers in the Specialty Retail industry. GCO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GCO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GCO was profitable.
In the past year GCO had a positive cash flow from operations.
In multiple years GCO reported negative net income over the last 5 years.
Of the past 5 years GCO 4 years had a positive operating cash flow.
GCO Yearly Net Income VS EBIT VS OCF VS FCFGCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of -1.12%, GCO perfoms like the industry average, outperforming 40.65% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.02%, GCO is in line with its industry, outperforming 46.34% of the companies in the same industry.
GCO has a Return On Invested Capital of 1.53%. This is comparable to the rest of the industry: GCO outperforms 43.09% of its industry peers.
GCO had an Average Return On Invested Capital over the past 3 years of 3.20%. This is significantly below the industry average of 11.99%.
Industry RankSector Rank
ROA -1.12%
ROE -3.02%
ROIC 1.53%
ROA(3y)0.75%
ROA(5y)1.21%
ROE(3y)1.82%
ROE(5y)2.91%
ROIC(3y)3.2%
ROIC(5y)N/A
GCO Yearly ROA, ROE, ROICGCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

GCO's Operating Margin of 0.89% is in line compared to the rest of the industry. GCO outperforms 42.28% of its industry peers.
In the last couple of years the Operating Margin of GCO has declined.
GCO's Gross Margin of 47.05% is fine compared to the rest of the industry. GCO outperforms 73.98% of its industry peers.
GCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.89%
PM (TTM) N/A
GM 47.05%
OM growth 3Y-51.59%
OM growth 5Y-30.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.1%
GM growth 5Y-0.51%
GCO Yearly Profit, Operating, Gross MarginsGCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GCO is destroying value.
GCO has less shares outstanding than it did 1 year ago.
GCO has less shares outstanding than it did 5 years ago.
There is no outstanding debt for GCO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GCO Yearly Shares OutstandingGCO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
GCO Yearly Total Debt VS Total AssetsGCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

GCO has an Altman-Z score of 2.44. This is not the best score and indicates that GCO is in the grey zone with still only limited risk for bankruptcy at the moment.
GCO has a Altman-Z score of 2.44. This is comparable to the rest of the industry: GCO outperforms 51.22% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that GCO is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.22, GCO is doing good in the industry, outperforming 60.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.44
ROIC/WACC0.15
WACC10.2%
GCO Yearly LT Debt VS Equity VS FCFGCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

GCO has a Current Ratio of 1.91. This is a normal value and indicates that GCO is financially healthy and should not expect problems in meeting its short term obligations.
GCO has a Current ratio of 1.91. This is amongst the best in the industry. GCO outperforms 82.93% of its industry peers.
A Quick Ratio of 0.55 indicates that GCO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.55, GCO is in line with its industry, outperforming 54.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 0.55
GCO Yearly Current Assets VS Current LiabilitesGCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

5

3. Growth

3.1 Past

GCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.65%, which is quite impressive.
GCO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.12% yearly.
Looking at the last year, GCO shows a small growth in Revenue. The Revenue has grown by 2.66% in the last year.
The Revenue has been growing slightly by 1.14% on average over the past years.
EPS 1Y (TTM)195.65%
EPS 3Y-50.35%
EPS 5Y-28.12%
EPS Q2Q%-37.35%
Revenue 1Y (TTM)2.66%
Revenue growth 3Y-1.35%
Revenue growth 5Y1.14%
Sales Q2Q%3.96%

3.2 Future

GCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.56% yearly.
Based on estimates for the next years, GCO will show a small growth in Revenue. The Revenue will grow by 2.57% on average per year.
EPS Next Y62.96%
EPS Next 2Y49.26%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue Next Year-0.17%
Revenue Next 2Y0.92%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GCO Yearly Revenue VS EstimatesGCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
GCO Yearly EPS VS EstimatesGCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 48.59 indicates a quite expensive valuation of GCO.
GCO's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.07. GCO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 15.78, the valuation of GCO can be described as correct.
Based on the Price/Forward Earnings ratio, GCO is valued a bit cheaper than 68.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GCO to the average of the S&P500 Index (22.59), we can say GCO is valued slightly cheaper.
Industry RankSector Rank
PE 48.59
Fwd PE 15.78
GCO Price Earnings VS Forward Price EarningsGCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GCO is valued cheaply inside the industry as 83.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6
GCO Per share dataGCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

GCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GCO's earnings are expected to grow with 46.56% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y49.26%
EPS Next 3Y46.56%

0

5. Dividend

5.1 Amount

GCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENESCO INC

NYSE:GCO (9/10/2025, 2:43:03 PM)

33.04

+1.36 (+4.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)12-04 2025-12-04/bmo
Inst Owners101.81%
Inst Owner Change6.63%
Ins Owners8.07%
Ins Owner Change5.71%
Market Cap356.17M
Analysts74.29
Price Target33.32 (0.85%)
Short Float %12.32%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.08%
Min EPS beat(2)-2.34%
Max EPS beat(2)0.18%
EPS beat(4)3
Avg EPS beat(4)21.84%
Min EPS beat(4)-2.34%
Max EPS beat(4)63.23%
EPS beat(8)5
Avg EPS beat(8)11.6%
EPS beat(12)8
Avg EPS beat(12)14.88%
EPS beat(16)12
Avg EPS beat(16)263.93%
Revenue beat(2)1
Avg Revenue beat(2)-2.29%
Min Revenue beat(2)-5.9%
Max Revenue beat(2)1.32%
Revenue beat(4)3
Avg Revenue beat(4)-0.36%
Min Revenue beat(4)-5.9%
Max Revenue beat(4)1.64%
Revenue beat(8)6
Avg Revenue beat(8)0.69%
Revenue beat(12)8
Avg Revenue beat(12)0.31%
Revenue beat(16)10
Avg Revenue beat(16)0.65%
PT rev (1m)33.33%
PT rev (3m)39.01%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)-61.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 48.59
Fwd PE 15.78
P/S 0.15
P/FCF N/A
P/OCF 17.29
P/B 0.68
P/tB 0.73
EV/EBITDA 6
EPS(TTM)0.68
EY2.06%
EPS(NY)2.09
Fwd EY6.34%
FCF(TTM)-3.07
FCFYN/A
OCF(TTM)1.91
OCFY5.78%
SpS217.2
BVpS48.44
TBVpS45.03
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -3.02%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.57%
ROICexgc 1.62%
OM 0.89%
PM (TTM) N/A
GM 47.05%
FCFM N/A
ROA(3y)0.75%
ROA(5y)1.21%
ROE(3y)1.82%
ROE(5y)2.91%
ROIC(3y)3.2%
ROIC(5y)N/A
ROICexc(3y)3.34%
ROICexc(5y)N/A
ROICexgc(3y)3.53%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y-55.02%
ROICexcg growth 5Y-26.41%
ROICexc growth 3Y-54.26%
ROICexc growth 5Y-24.94%
OM growth 3Y-51.59%
OM growth 5Y-30.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.1%
GM growth 5Y-0.51%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.55
Cap/Depr 101.96%
Cap/Sales 2.29%
Interest Coverage 4.68
Cash Conversion 28.03%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 0.55
Altman-Z 2.44
F-Score4
WACC10.2%
ROIC/WACC0.15
Cap/Depr(3y)113.44%
Cap/Depr(5y)103.5%
Cap/Sales(3y)2.29%
Cap/Sales(5y)2.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.65%
EPS 3Y-50.35%
EPS 5Y-28.12%
EPS Q2Q%-37.35%
EPS Next Y62.96%
EPS Next 2Y49.26%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue 1Y (TTM)2.66%
Revenue growth 3Y-1.35%
Revenue growth 5Y1.14%
Sales Q2Q%3.96%
Revenue Next Year-0.17%
Revenue Next 2Y0.92%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y160.08%
EBIT growth 3Y-52.25%
EBIT growth 5Y-29.24%
EBIT Next Year333.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.04%
FCF growth 3Y-36.89%
FCF growth 5Y-11.76%
OCF growth 1Y115.46%
OCF growth 3Y-28.45%
OCF growth 5Y-5.59%